Tenderwize
Retour à la recherche

Supply of Pharmaceutical Products

МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - БОТЕВГРАД ЕООД·гр. Ботевград, Bulgaria·BGN 566.2k·Deadline Sep 26, 2028 · 760 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Bulgaria – Pharmaceutical products – Динамична система за покупки ДОСТАВКА НА ЛЕКАРСТВЕНИ ПРОДУКТИ ЗА НУЖДИТЕ НА „МБАЛ - БОТЕВГРАД“ ЕООД за период от 3 години

40/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

50 / 100

Facteurs de risque

No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...

Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • BGN 566.2k estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 36 MONTH
  • Supply of pharmaceutical products (CPV 33600000) to MBAL-Botevgrad Hospital.
  • DPS duration of 36 months.
Afficher le résumé complet

This notice establishes a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to MBAL-Botevgrad Hospital in Bulgaria for a period of 3 years. The DPS is divided into a single lot covering all pharmaceutical products. The estimated total value is 566,202 BGN. The procedure is restricted, with award based on lowest price. Participation requires a wholesale authorization for medicinal products. The notice publication date is 2025-09-29, and the deadline for admission to the DPS is 2028-09-26. No procurement documents were analyzed.

Risques

No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...

Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must hold a wholesale authorization for medicinal products issued by the Bulgarian Drug Agency or equivalent.

Administrative

  • Must submit an ESPD (European Single Procurement Document) with Part IV, Section A completed.
  • Electronic submission via the CAIS EOP platform is required.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Lowest price (no weight specified).

Acheteur

Localisation

гр. Ботевград, BGR

Profil acheteur

Ouvrir le profil

Identifiant

000770022

Activité

Health

Lots (1)

LOT-0001

Supply of Pharmaceutical Products

Supply of various medicinal products to MBAL-Botevgrad Hospital over a 3-year period. Quantities are indicative and non-binding.

SuppliesDPSEU fundedElectronic submission

BGN 566.2k

Valeur estimée

Localisation

Ботевград, Bulgaria

Durée

36 MONTH

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Sep 26, 2028

Détails de la procédure

Date de publication
28 Sep 2025
Langues
Bulgarian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
633535-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30